Immunovant shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Immunovant
Tip: Access up to 7 years of quarterly data
All positions including Immunovant held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Immunovant by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $11M | 349k | 32.31 |
| 2023-12-31 | $19M | 458k | 42.13 |
| 2023-09-30 | $20M | 510k | 38.39 |
| 2023-06-30 | $6.2M | 325k | 18.97 |
| 2023-03-31 | $6.8M | 441k | 15.51 |
| 2022-12-31 | $6.6M | 371k | 17.75 |
| 2022-06-30 | $955k | 245k | 3.90 |
| 2022-03-31 | $2.0M | 356k | 5.51 |
| 2021-12-31 | $2.5M | 294k | 8.52 |
| 2021-09-30 | $4.0M | 459k | 8.69 |
| 2021-03-31 | $17M | 1.0M | 16.04 |
| 2020-12-31 | $36M | 787k | 46.19 |
| 2020-09-30 | $4.3M | 123k | 35.19 |
| 2020-06-30 | $3.7M | 151k | 24.35 |